Atlas Trials

Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function

Clinical trial NCT02452801 · COMPLETED

Trial details

NCT number
NCT02452801
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2015-05-01
Primary completion
2015-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.